Sunday, March 03, 2013 3:55:10 PM
Looks like the Prurisol POC trial in Europe will be later than originally expected. From the company PR on February 25th:
Dr. Reddy’s has completed the process development of Prurisol and is now in the formulation stage for the manufacturing of Prurisol for the upcoming clinical trials in Europe planned for the second quarter of 2013.
My understanding is that, as part of the formulation stage, Dr. Reddy's must verify that the drug is stable for a 60 day period, ie, once they've produced a batch using the final manufacturing process, they must test it, store it for 60 days, and re-test it, to verify it has remained stable over that time.
If they finish the first batch using the final manufacturing process by the end of March, the schedule might look like:
Initial test: 1 week (finish on April 7th)
Store for 60 days: 60 days (End on June 1st)
Final test: 1 week (finish on June 8th)
This implies that the POC would start around the end of June, assuming all goes well.
Assuming all patients in the trial begin the trial by July 15th, and the trial takes 60 days (30 days of dosing, followed by a follow-up 30 days after the end of dosing), puts the end of the trial at Sept. 15th. Assuming 15 days to analyze the data and put out a press release puts the date for a PR on the Prurisol POC trial around Oct. 1 - significantly later than I'd been expecting.
A1
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM